Scientific Research and Development

The Scientific Research and Development team at GentiBio is responsible for advancing the company's pipeline of engineered regulatory T cells (EngTregs). This team conducts cutting-edge research to develop and optimize novel therapeutic approaches aimed at treating autoimmune, alloimmune, autoinflammatory, and allergic diseases. They integrate advanced technologies in Treg biology and synthetic immunology to restore immune tolerance and overcome limitations of current T-cell therapies. Their work includes discovery science, preclinical development, assay development, and in-vivo pharmacology to ensure the efficacy and safety of these groundbreaking treatments.